Приказ основних података о документу

dc.creatorRadulović, Dušanka
dc.creatorKarljiković-Rajić, Katarina
dc.creatorLucić, BM
dc.creatorVujić, Zorica
dc.date.accessioned2019-09-02T10:53:26Z
dc.date.available2019-09-02T10:53:26Z
dc.date.issued2001
dc.identifier.issn0731-7085
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/295
dc.description.abstractThe inclusion complex formation between Metoprolol tartarata (MeT) and beta -cyclodextrin (beta -CD) has been investigated using hyperchromic shift at lambda (max) 274.4 nm of MeT. Different parameters such as stirring time, solvent composition (aqueous and aqueous/methanol solutions with methanol content up to 50%), pH values 4.0 and 8.0 were established for optimal inclusion complex formation and confirmed two stoichiometric compositions 1:1 and 1:2. Preliminary data. on usage of MeT/beta -CD complex in reversed-phase HPLC indicate the potential application of this complex as a kind of pre-column derivatization for enantiomeric separation of beta (1)-blockers.en
dc.publisherPergamon-Elsevier Science Ltd, Oxford
dc.rightsrestrictedAccess
dc.sourceJournal of Pharmaceutical and Biomedical Analysis
dc.titleA preliminary study of beta-cyclodextrin/metoprolol tartrate inclusion complex for potential enantiomeric separationen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractРадуловић, Душанка; Карљиковић-Рајић, Катарина; Вујић, Зорица; Луцић, БМ;
dc.citation.volume24
dc.citation.issue5-6
dc.citation.spage871
dc.citation.epage876
dc.citation.other24(5-6): 871-876
dc.citation.rankM22
dc.identifier.wos000167764200015
dc.identifier.doi10.1016/S0731-7085(00)00555-0
dc.identifier.pmid11248480
dc.identifier.scopus2-s2.0-0035091312
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу